Gremlin-1 Drives Tumour Vascularization by Promoting Endothelial Differentiation and Angiogenesis.

Area of Science:

• Developmental Biology
• Cancer Biology
• Vascular Biology

Background:

• Gremlin-1, a BMP signalling antagonist, is highly expressed in malignant tumors and linked to poor prognosis.
• Its role in tumor endothelial differentiation and vascularization is not fully understood.
• Gremlin-1 is known to possess pro-angiogenic activity.

Purpose of the Study:

• To investigate gremlin-1's contribution to tumor vascularization.
• To determine if gremlin-1 promotes endothelial differentiation and vascular recruitment.
• To elucidate the mechanism by which gremlin-1 influences tumor growth.

Main Methods:

• Murine embryonic stem cells (ESCs) engineered to express gremlin-1 were used for in vitro tumoroid development.
• In vivo studies involved gremlin-1-expressing ESCs generating teratomas in mice.
• The chick chorioallantoic membrane (CAM) assay was employed to assess graft vascularization and endothelial cell origins.

Main Results:

• Gremlin-1 expression in ESCs promoted in vitro tumoroid development with mesodermal and endothelial lineages, marked by CD31 expression.
• In vivo, gremlin-1-expressing ESCs formed larger teratomas with increased vascularization.
• The CAM assay showed gremlin-1-expressing grafts had enhanced growth and vascularization, involving both donor and host endothelial cells.

Conclusions:

• Gremlin-1 regulates tissue vascularization by integrating intrinsic endothelial differentiation with extrinsic angiogenic responses.
• This mechanism is relevant to vascular remodeling in pathological conditions, including tumor growth.
• Gremlin-1 acts as a crucial factor in promoting tumor vascularization.